Food, drugs, devices › West-Ward Columbus, Inc.

Drug recall: Doxercalciferol Capsules 0.5mcg, 50 count bottles, Rx, only, Manufactured by Cipla Limited Kurkumbh, Maharashtra, India,

FDA enforcement event 76822 · Class III · initiated 4 Apr 2017 · status Terminated · terminated 4 Sep 2018

DrugVoluntary: Firm initiated1 product recordColumbus, OH

West-Ward Columbus, Inc. (Columbus, OH) initiated this drug recall on 4 Apr 2017; FDA lists 1 product record under event 76822, classified Class III.

FDA defines Class III as a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences. 30% of the 343 drug enforcement events initiated in 2017 carry the same class.

Status: Terminated, terminated 4 Sep 2018. Initiation: voluntary: firm initiated. West-Ward Columbus, Inc. has 9 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

West-Ward Columbus, Inc., Columbus, OH.

Reason for recall

"Failed Tablet/Capsule Specifications; during an internal inspection, capsules were found with illegible print."

Distribution

"The recalled product was distributed to the following state: OH. There are no Canada accounts for this recall. There are no Mexico accounts for this recall. There are no government accounts for this…"

Product records

Recall number	Product	Quantity	Class	Status	Report date
D-0651-2017	Doxercalciferol Capsules 0.5mcg, 50 count bottles, Rx, only, Manufactured by Cipla Limited Kurkumbh, Maharashtra, India, Manufactured for West-Ward, Pharmaceuticals, Corp., Eatontown, NJ -- NDC 0054-0338-19	100 bottles	Class III	Terminated	19 Apr 2017

Context

30%of 2017 drug events are Class III343 events that year

1product record in this eventfirm median: 1

9events on this register for the firm

Other enforcement events for West-Ward Columbus, Inc.

Initiated	Product (first record)	Type	Class	Records
19 Dec 2024	Methadone Hydrochloride Tablets, USP, 5mg, 10x10 Unit-Dose Tablets, Rx Only, Distributed by: Hikma Pharmaceuticals USA I	Drug	Class III	1
22 Sep 2023	Methotrexate Tablets, USP, 2.5 mg, 10x10 Unit-Dose Tablets per carton, Rx only, Distributed by: West-Ward Pharmaceutical	Drug	Class III	1
22 Jul 2020	Leucovorin Calcium Tablets USP, 10 mg, Rx only, 24 Tablets per bottle, Distr. by: West-Ward Pharmaceuticals Corp. Eatont	Drug	Class III	1
13 May 2020	Doxycycline Hyclate Tablets USP, 100 mg, packaged in a) 50-count bottle (NDC 0143-2112-50), b) 500-count bottle (NDC 014	Drug	Class II	1
13 May 2020	Ethacrynic Acid Tablets USP, 25 mg, 100 Tablets per Bottle, Rx only, Distr. by: West-Ward Pharmaceuticals Corp., Eatonto	Drug	Class III	1
9 Sep 2019	Oxcarbazepine Oral Suspension, USP, 300 mg/5 mL, 250 mL per bottle, Rx Only, Distr. by: West-Ward Pharmaceuticals,Eatont	Drug	Class II	1
24 Jul 2018	Doxycycline Hyclate Tablets, USP, 100 mg*. 50-count bottle, Rx only. Manufactured by: West-Ward Pharmaceuticals Corp. Ea	Drug	Class II	2
19 May 2016	Oxycodone HCl, Oral Solution USP, 5 mg/5 mL, 15 mL bottles, Rx only, Boehringer Ingelheim Roxane, Inc., Columbus, OH ---	Drug	Class III	1

All 9 events for West-Ward Columbus, Inc.

Questions and answers

Why was this drug recalled?

FDA's record gives the reason for recall as: "Failed Tablet/Capsule Specifications; during an internal inspection, capsules were found with illegible print."

What does Class III mean?

FDA classifies recalls by relative degree of health hazard. Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.

Where was the product distributed?

FDA's distribution pattern field reads: "The recalled product was distributed to the following state: OH. There are no Canada accounts for this recall. There are no Mexico accounts for this recall. There are no government accounts for this…"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 4 Sep 2018. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA drug enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.